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ABSTRACT
Increases in glomerular size occur with normal body growth and in many pathologic conditions. In this study, we
determined associations between glomerular size and numbers of glomerular resident cells, with a particular
focus onpodocytes. Kidneys from16maleCaucasian-Americanswithout overt renal disease, including 4 children
(#3 years old) to deﬁne baseline values of early life and 12 adults ($18 years old), were collected at autopsy in
Jackson, Mississippi. We used a combination of immunohistochemistry, confocal microscopy, and design-based
stereology to estimate individual glomerular volume (IGV) and numbers of podocytes, nonepithelial cells (NECs;
tuft cells other than podocytes), and parietal epithelial cells (PECs). Podocyte density was calculated. Data are
reported as medians and interquartile ranges (IQRs). Glomeruli from children were small and contained 452
podocytes (IQR=335–502), 389 NECs (IQR=265–498), and 146 PECs (IQR=111–206). Adult glomeruli contained
signiﬁcantly more cells than glomeruli from children, including 558 podocytes (IQR=431–746; P,0.01), 1383
NECs (IQR=998–2042; P,0.001), and 367 PECs (IQR=309–673; P,0.001). However, large adult glomeruli
showed markedly lower podocyte density (183 podocytes per 106 mm3) than small glomeruli from adults and
children (932 podocytes per 106 mm3; P,0.001). In conclusion, large adult glomeruli contained more podocytes
than small glomeruli from children and adults, raising questions about the origin of these podocytes. The in-
creased number of podocytes in large glomeruli does not match the increase in glomerular size observed in
adults, resulting in relativepodocytedepletion. Thismay renderhypertrophicglomeruli susceptible topathology.
J Am Soc Nephrol 26: ccc–ccc, 2015. doi: 10.1681/ASN.2014070641
CKD is a global pandemic.1 There aremultiple causes
of CKD, and although each cause of CKD shows a
particular pathophysiology, most share common fea-
tures. Arguably, the most signiﬁcant of these is
podocyte injury or dysfunction.2
Podocytes have a highly specialized structure
and a very limited capacity to replicate under
normal circumstances.3 As major components of
the glomerular ﬁltration barrier, they fulﬁll a num-
ber of important functions, including structural
support to capillary loops, synthesis of components
of the glomerular basement membrane, synthesis
and secretion of several cytokines and growth fac-
tors, and immunologic functions.4 Consequently,
podocyte injury comes at a high price for the glo-
merulus.
In recent years, the podocyte depletion hypothesis
has emerged as a unifying concept in the pathogenesis
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of glomerular disease.5 On the basis of multiple observations in
animal models,4,6–10 podocyte depletion can be deﬁned as ab-
solute when it involves a reduction in the total number of
podocytes per glomerulus.11,12 In a landmark study, Wharram
et al.5 showed that a 40% reduction in podocyte number is a
direct cause of FSGS and therefor, long-standing CKD in rats. To
date, a similar threshold has not been deﬁned in humans.
Relative podocyte depletion occurs when the number of
podocytes doesnot keeppace ormatch an increase in glomerular
volume or ﬁltration surface area. Glomerular size increases with
normal body growth as well before and during multiple renal
pathologies, including both diabetic nephropathy13–17 and
FSGS.18–24 It has been suggested that an increase in glomerular
size (also known as glomerular hypertrophy) is usually a com-
pensatorymechanism that serves tomatch physiologic demands
and sustain renal function.25 Over the last decade, our group has
described multiple factors associated with compensatory glo-
merular hypertrophy in humans without overt renal disease,
including older age, low nephron number (Nglom), obesity, hy-
pertension, and African-American race.26 Interestingly, the
boundary between compensatory and pathologic hypertrophy
remains unclear and may be associated with relative podocyte
depletion.
Despite the current interest inpodocyte depletion, few studies
to date have reported total numbers of podocytes in normal
glomeruli.27–32 This is, in part, because of the difﬁculty in count-
ing podocytes and the lack of consensus on how to accurately
count them. Lemley et al.11 recently compared ﬁve methods
for estimating podocyte number and recommended that the
design–based dissector/optical fractionator method was the opti-
mum technique when sufﬁcient kidney tissue was available.
This method provides an estimate of the volume of individual glo-
meruli as well as the total numbers of each of the resident glo-
merular cells, including podocytes, endothelial cells, mesangial
cells, and parietal epithelial cells (PECs).12 It, thus, provides an
ideal tool to analyze both absolute and relative podocyte deple-
tion and associations with numbers of other glomerular resident
cell types.
In this study, we used design-based stereology to estimate
glomerular volume and the numbers of podocytes and other
resident glomerular cells in kidneys collected at autopsy in
Caucasian-American boys and men. Our ﬁndings provide new
insights into possible changes in glomerular cell populations in
thecontextofglomerularhypertrophy inthenondiseasedkidney,
and they suggest that large adult glomeruli have relative podocyte
depletionandtherefore,maybesusceptible tothedevelopmentof
pathology.
RESULTS
General Demographics
General demographics of four children are provided in Table 1.
Brieﬂy, all four children were 3 years of age or younger and
presented no complications during pregnancy. Body surface
area at the time of death ranged from 0.31 to 0.71 m2. Causes
of death for all children were not cardiovascular-related, and
there were no signs of hypertension in these subjects. All chil-
dren had adequate birth weights for gestational age and there-
fore, nephron number values.0.6 million,33 both of which can
serve as good surrogate markers of a normal fetomaternal envi-
ronment.26 These four subjects provided a baseline to identify
changes in glomerular size and cellularity in adulthood.
General demographics for 12 adult subjects are provided in
Table 2. The youngest adult was 25 years old, whereas the oldest
adult was 49 years of age; 50% of the adult subjects were either
overweight or obese (body mass index$25.0 but ,40 kg/m2).
Body surface area ranged from 1.45 to 2.64 m2, Nglom ranged
from 0.55 to 1.66 million, and Nglom/body surface area ranged
from1.06 to 0.55million/m2. Birthweightwas normal (.2.5 and
,4.0 kg34) in those subjects with available data (n=8). Five adults
were hypertensive, and ﬁve adults had cardiovascular-related
deaths. Additional information regarding pathologic analysis of
these kidneys, including glomerulosclerosis, cortical ﬁbrosis, and
arteriosclerosis, is provided in Supplemental Table 1.
Glomerular Volumes and Cell Numbers
Individual glomerular volume (IGV) was estimated in a total of
480 glomeruli (30 per subject). The three smallest and the three
largest glomeruli per subject (10th and 90th percentiles; n=96
glomeruli) were selected for additional cellular analysis. Podocytes
were identiﬁed according to several criteria (Figure 1, A and A9),
namely speciﬁc cytoplasmic immunostaining for Wilms’
Tumor 1 (WT-1) (Figure 1, B and B9), presence of major cyto-
plasmic projections (Figure 1B9), and nuclear location outside
capillary loops.When possible, lack of immunostaining for vWF
(Figure 1, C and C9) was also used as part of these criteria. Be-
cause of the unexpected expression of WT-1 in the cytoplasmic
compartment, we provide additional details regarding the spec-
iﬁcity of this marker. Although WT-1 and Synaptopodin (SNP)
were expressed within the same cells (Supplemental Figure 1),
WT-1 was present in the cell body and major processes, whereas
SNP was mostly located in foot processes. Furthermore, WT-1
was consistently found in the podocyte cytoplasm and tissue
from nephrectomies and biopsies (Supplemental Figure 2).
Initially, we intended to use immunostaining for vWF to
identify endothelial cells. However, vWF staining was not
consistent in all autopsy samples, and we, therefore, classiﬁed
all cells on the glomerular tuft that were not podocytes as
nonepithelial cells (NECs; the majority of these cells were
endothelial and mesangial cells). PECs were identiﬁed by their
location on Bowman’s capsule.
Glomerular Size Differs Signiﬁcantly between Children
and Adults
Representative light microscopic images of glomeruli from
children and adults are provided in Figure 2, A and B, respec-
tively. IGV estimates for 96 glomeruli in 16 subjects ranked by
median IGV are shown in Figure 2C. Considerable variation in
glomerular size was present in children, but this was far greater
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in adults. Adults showed greater aggregatedmedian IGV (Figure
2D) (P,0.001) and IGV variance (Figure 2E) (P,0.01) than
children. Median IGV in children was 0.413106 mm3 (inter-
quartile range [IQR]=0.293106 mm3–0.643106 mm3), and in
adults, it was 2.423106 mm3 (IQR=1.543106 mm3–3.273106
mm3), a 5.9-fold difference. Figure 2F shows the marked right
shift in the adult IGV distribution compared with that in chil-
dren. The smallest glomerulus observed in children had a vol-
ume of 0.213106 mm3, whereas the largest had a volume of
0.893106 mm3—a difference of 0.683106 mm3 or 4.2-fold. In
contrast, the smallest glomerulus in adults had a volume of
0.763106 mm3, whereas the largest had a volume of 6.913106
mm3, a difference of 6.153106 mm3 or 9.1-fold.
Numbers of Glomerular Cells Differ Signiﬁcantly
between Children and Adults
Representative confocal images showing the marked differences
in glomerular cellularity between children and adults are shown
in Figure 3, A andB. Aggregated data for total numbers ofNECs,
podocytes, and PECs in children (n=24 glomeruli) and adults
(n=72 glomeruli) are reported in Figure 3, C and D, and they
clearly show the greater variability in adult cell numbers. In adult
glomeruli, the median podocyte count was 558 (IQR=431–746;
3.7-fold), whereas median NEC and PEC counts were 1383
(IQR=998–2042; 7.0-fold) and 367 (IQR=309–673; 10.3-fold),
respectively. In children, the median podocyte count was 452
(IQR=335–502; 2.1-fold), whereas median NEC and PEC counts
were 389 (IQR=265–498; 4.2-fold) and 146 (IQR=111–206; 2.8-
fold), respectively.
Numbers of Glomerular Cells in the Context of
Glomerular Hypertrophy
The estimation of absolute numbers of speciﬁc cell types in
glomeruli of known volume allowed us to examine relation-
shipsbetweenglomerular size andnumbersof eachcell type.As
seen in Figure 4A, IGV was directly and strongly associated
with the numbers of NECs (aggregated R=0.96, children
R=0.83, adult R=0.92; P,0.001 in each case). In a linear re-
gression analysis of aggregated glomeruli (from children and
adults), 92% of IGV variability was explained by numbers of
NECs (F=1084; P,0.001), predicting an increase of 544 NECs
per 106 mm3 glomerular tuft volume. Similarly, IGV was
Table 1. Demographic data for four male Caucasian-American children without kidney disease
Ranka Age (yr) GA (wk) BS Area (m2) Nglom (million)
Nglom/BS Area
(million/m2)
Birth Weight (kg)
Hypertensive
Status
COD CVRD
Ch1 0.25 35 0.36 1.11 3.08 2.92 Normotensive SIDS No
Ch2 0.50 39 0.31 0.84 2.71 3.54 Normotensive Other No
Ch3 3.00 38 0.71 1.22 1.72 2.80 Normotensive Accident No
Ch4 3.00 41 0.68 0.90 1.32 3.63 Normotensive Accident No
Median 1.75 38.50 0.52 1.01 2.22 3.23 0% NA 0%
IQR 0.3–3.0 35.8–40.5 0.3–0.7 0.9–1.2 1.4–2.9 2.8–3.6 NA NA NA
GA, gestational age at birth; BS area, body surface area;Nglom, total nephron number; COD, cause of death; CVRD, cardiovascular-related death; Ch, child; SIDS,
sudden infant death syndrome; Other, hematologic, neoplastic, or infectious; NA, not available.
aSubjects were ranked on the basis of median IGV.
Table 2. Demographic data for 12 adult Caucasian-American men without kidney disease
Ranka
Age
(yr)
BMI
(kg/m2)
BS Area
(m2)
Nglom
(million)
Nglom/BS Area
(million/m2)
Birth Weight
(kg)
Hypertensive
Status
COD CVRD
A1 43 18.19 1.57 1.66 1.06 3.38 Hypertensive Other No
A2 25 18.10 1.45 0.69 0.48 NA Normotensive Other No
A3 31 30.80 1.86 1.05 0.57 3.25 Normotensive Accident No
A4 41 34.02 2.36 1.12 0.47 3.86 Normotensive CAD Yes
A5 41 23.02 1.80 0.83 0.46 3.66 Normotensive Other No
A6 25 23.80 1.72 0.95 0.55 NA Normotensive Cardiac, not CAD Yes
A7 47 22.75 1.81 1.15 0.64 NA Normotensive Accident No
A8 48 20.54 1.94 1.00 0.52 NA Normotensive Other No
A9 37 36.36 2.17 0.93 0.43 3.29 Hypertensive CAD Yes
A10 49 35.88 2.31 0.78 0.34 3.12 Hypertensive CAD Yes
A11 37 39.42 2.64 0.76 0.29 3.23 Hypertensive Other No
A12 39 26.70 2.01 0.55 0.27 3.46 Hypertensive CAD Yes
Median 40 25.53 1.9 0.94 0.47 3.34 42% NA 42%
IQR 33–46 22.8–35.4 1.7–2.3 0.8–1.1 0.4–0.6 3.2–3.6 NA NA NA
BMI, body mass index; BS area, body surface area; Nglom, total nephron number; COD, cause of death; CVRD, cardiovascular-related death; A, adult; Other, in-
fectious, hematologic, neoplastic, or central nervous system-related but not cardiovascular or pulmonary; NA, not available; CAD, coronary artery disease.
aSubjects were ranked on the basis of median IGV.
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closely directly associated with PEC number (aggregated
R=0.88, children R=0.78, adults R=0.86; P,0.001 in each
case) (Figure 4B). A linear regression model predicted an in-
crease of 141 PECs per 106mm3 glomerular tuft volume (R2=0.79;
F=357; P,0.001).
Unlike the situation with PECs and NECs, the association
between IGV and podocyte number (Figure 5A) was weaker in
adults than in children (aggregated R=0.70, children R=0.87,
adults R=0.76; P,0.001 in each case). The adult relationship
between number of podocytes and IGV was better ﬁtted in a
quadratic model (Figure 5A), with podocyte number plateauing
with IGV values approximately .43106 mm3. Because of the
great variability in IGV in adults, we also examined the relation-
ships between podocyte number and glomerular size in children
and between tertiles of glomerular size in adults. As shown by
Figure 5B, glomeruli from children contained the same number
of podocytes as small and medium adult glomeruli (P.0.05).
However, large adult glomeruli (tertile 3) contained signiﬁcantly
more podocytes than glomeruli from children and small and
medium adult glomeruli (P,0.01). Figure 5C shows that adult
glomeruli (all three tertiles) had lower podocyte densities
(podocyte number per 106 mm3 glomerular tuft volume)
than glomeruli from children (P,0.01 for small glomeruli;
P,0.001 for medium and large glomeruli). Large adult glo-
meruli had a signiﬁcantly lower podocyte density than small
andmedium adult glomeruli (P,0.05 for medium glomeruli;
P,0.001 for small glomeruli).
Cell Ratios in the Context of
Glomerular Hypertrophy
Figure 6A illustrates differences in the
trajectories of numbers of NECs and
podocytes in the context of IGV (F=550;
P,0.001). Although small glomeruli had
similar numbers of NECs and podocytes
(indeed, podocytes slightly outnumbered
NECs), in adult glomeruli, NECs outnum-
bered podocytes (Figure 6B), and this was
most pronounced in large adult glomeruli,
in which the NEC-to-podocyte ratio was
close to 3:1. In contrast, the trajectories of
both PEC number and podocyte number
with IGV were not statistically different
(P.0.05) (Figure 6C). However, the ratio
of PECs/podocyte was signiﬁcantly higher
in adult glomeruli than children glomeruli
(1:3; P,0.001 for all tertiles) and large
(1:1) compared with small (1:2) adult glo-
meruli (Figure 6D).
Histologic Evidence of Possible
Sources of Podocytes
WT-1+PECs (also known as parietal
podocytes) were found in approximately
90% of glomeruli in both children and
adults. These cells were typically found close
to the vascular pole and never observed near the tubular pole
(Figure 7, A and A9). WT-1+cells were also occasionally ob-
served in the tunica intima and the tunica media of arterioles
in the juxtaglomerular apparatus (JGA) (Figures 7, B and B9).
Zonal Analyses in Adult Glomeruli
From 72 sampled adult glomeruli, 31 glomeruli were located in
the outer cortex (superﬁcial), 24 glomeruli were located in the
middle cortex, and 17 glomeruli were located in the inner cortex
(juxtamedullary). There were no zonal differences in IGV,
podocyte number, or podocyte density (Supplemental Figure 3).
DISCUSSION
The three major ﬁndings of this study were (1) glomerular size
and numbers of glomerular cells vary widely in children and
adults without overt kidney disease, with greater variation seen
in adults; (2) large adult glomeruli contain more podocytes than
glomeruli from four young children and small adult glomeruli;
and (3) these large adult glomeruli have a lower podocyte density,
which may leave them in a setting of relative podocyte depletion.
Glomerular hypertrophy plays pivotal roles in the develop-
ment of FSGS2,18,19 and the progression of diabetic nephropa-
thy,35–38 two of the most common causes of CKD. According to
the hyperﬁltration theory,25 an imbalance between glomerular
mass and physiologic requirements drives glomerular
Figure 1. Podocyte identiﬁcation. (A) A representative confocal image of a glomerular
tuft is shown (merged) using (B) WT-1 (green; speciﬁc podocyte marker), (C) vWF (red;
speciﬁc endothelial cell marker), and DAPI (blue; nuclear marker). The corresponding
insets show our podocyte identiﬁcation criteria: (A9) expression of WT-1 in podocyte
cytoplasm, (B9) lack of expression of vWF, and (C9) their location outside capillaries.
Arrowheads show classic podocyte morphology (major projections). Scale bars, 10
mm. DAPI, 49,6-diamidino-2-phenylindole.
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hypertrophy as an appropriate compensatory response to sus-
tain renal function. We hypothesize that human glomerular
growth is initially a healthy compensatory step, which if exag-
gerated, can result in pathology.
Human glomeruli have been reported to increase in size
up to 7-fold from infancy to adulthood.39,40 These ﬁndings
conﬁrm this signiﬁcant increase in glomerular size from child-
hood to adulthood, although it is important to note that kid-
neys from only four children were analyzed in this study. We
report a 5.9-fold increase in glomerular volume between
childhood and adulthood and show a much greater variability
in glomerular sizes in adults than in children. This latter ﬁnd-
ing suggests that the great variability in IGV found within and
between adults may be established later in life.41 We have pre-
viously reported that increased IGV median and variance in
adult American men are closely associated with low nephron
number,33 older age,42 obesity,43 African-American race,44
and hypertension.45 This study suggests that glomerular hy-
pertrophy is initially associated with body growth from
childhood to adulthood. Additional adult hypertrophy oc-
curs in association with aging, nephron loss, hypertension,
and obesity—all variables that can be present individually or
combined, reﬂecting the multifactorial nature of glomerular
hypertrophy.41,46
Todate,onlyahandfulofstudieshaveestimatedtotalpodocyte
number in adult human glomeruli, and these studies focused on
pathology. Studies of type 2 diabetes identiﬁed absolute podocyte
depletion in the early stages of diabetic nephropathy, which was
closely related to disease progression.27–30 Absolute podocyte
depletion was also reported in studies of IgA nephropathy and
hypertensive nephrosclerosis.31,32 Although these studies pro-
vided valuable insights into the association between podocyte
number and the development and progression of renal disease,
our study shows, for the ﬁrst time, that podocyte number varies
within and between subjects without overt renal disease.
In this study, median podocyte number per adult glomerulus
was558,withthelowestcountbeing263podocytesandthehighest
countbeing983podocytes(3.7-foldrange).Thisﬁndingraises two
important questions. (1)When is podocyte number determined?
(2)What is the optimal number of podocytes required in an adult
glomerulus? These questions are considered in turn.
These ﬁndings provide several novel insights into the
establishment of adult podocyte number. Glomeruli in four
young children contained fewer podocytes than large adult
glomeruli; .30 years ago, Olivetti et al.47 described a similar
pattern between young, adult, and uninephrectomized rats.
Taken together, these ﬁndings suggest that additional podocytes
may be acquired by certain glomeruli after early childhood. The
Figure 2. Glomeruli from adults are larger and have more variable size than glomeruli from children. A and B show representative images of
average glomeruli from children and adults, respectively, using periodic acid–Schiff staining. (C) IGV values in 16 Caucasian-American men
and boys. Each circle represents one glomerulus, and each column represents one subject with 30 glomeruli per subject; Ch1–Ch4 rep-
resent four young children (gray), and A1–A12 represent 12 adults (white) ranked by median IGV. (D) Aggregated IGV differences between
children and adults. (E) Difference in IGV variance per subject between glomeruli from children and adults. (F) IGV distributions in children
(solid line with gray area) and adults (dotted line). Bars represent median values with IQR. Scale bars, 50 mm. **P,0.01; ****P,0.001.
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origin of these additional podocytes remains unknown, but in
recent years, there has been great interest in the topic of podocyte
replacement in the postnatal period.
Mature podocytes exit the cell cycle to take on a terminally
differentiated phenotype and express cyclin–dependent kinase
inhibitors, such as p16INK4a, P21Cip1,
P27Kip1, and P57Kip2.48–52 After this point,
podocytes are considered incapable of un-
dergoing mitosis under normal conditions,
although podocyte proliferation occurs in
certain pathologic conditions, such as HIV-
associated nephropathy.53,54 Podocytes can
be induced to proliferate in vitro when cul-
tured from freshly isolated glomeruli,55 but
these cells express low levels of many of the
podocyte–speciﬁc differentiation markers,
suggesting that podocytes are only capable
of proliferating after they have dedifferenti-
ated to a certain degree. Recent evidence sug-
gests that progenitor cells residing in the
JGA56 and Bowman’s capsule (PECs)57–61
may give rise to podocytes. Other lines of
evidence suggest that new podocytes may
arise from bone marrow.62–64 In this study,
WT-1+PECs (parietal podocytes) were observed near the vas-
cular pole in most glomeruli in children and adults, and some
WT-1+cells were occasionally observed in the tunica intima and
the tunica media of arterioles in the JGA. Whether any of these
cells give rise to new podocytes deserves additional attention.
Figure 3. Large glomeruli from adults contained more podocytes, NECs and PECs than glomeruli from children. A and B show
representative confocal images of glomeruli from children and adults, respectively, with WT-1 (green), vWF (red), and DAPI (blue). C and
D show the numbers of NECs, PECs, and podocytes per glomerulus from children and adults. C illustrates the variability of each cell type
between glomeruli from adults and children; each circle represents the value for a single glomerulus,. D provides details of the medians,
IQRs (25% and 75% percentiles), minimum andmaximum values, and fold ranges per group. Scale bars, 100 mm. DAPI, 49,6-diamidino-2-
phenylindole. **P,0.01; ***P,0.001.
Figure 4. Glomerular size is closely associated with numbers of NECs and PECs. (A)
Association between IGV and numbers of NECs in glomeruli from children (gray) and
adults (white). (B) Association between IGV and PECs in glomeruli from children (gray)
and adults (white).
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There is much interest in whether PECs can give rise to
podocytes.59,65 Wanner et al.66 recently showed that podocyte
generation is mainly active during glomerular development and
may occur after acute glomerular injury but was not observed in
aging kidneys or in response to nephron loss. Interestingly, a
recent study by Berger et al.67 showed that
parietal podocytes (PECs expressing podocyte
markers) disappeared from Bowman’s cap-
sule as glomeruli gradually underwent phys-
iologic hypertrophy, suggesting that there is
a functional podocyte reserve that directly
differentiates into podocytes on Bowman’s
capsule. Berger et al.68 proposed that this is
explained by the lack of space to accommo-
date podocytes on the small glomerular tuft
of a young child. This hypothesis is sup-
ported by our ﬁndings that show that glo-
meruli from young children are small and
replete with podocytes (high podocyte nu-
merical density) but have a lower podocyte
number than large glomeruli from adults.
A novel method on the basis of ﬂow
cytometry was used recently to report a 7%
increase in podocyte number after acute
podocyte injury.66 This is an interesting ap-
proach that has many advantages (i.e., does
not rely on time-consuming techniques).
However, we believe that stereologic meth-
ods may also provide an important per-
spective. For example, stereology-based
approaches consider the context of glomer-
ular size and cortical location, both of which
have signiﬁcant value. We believe that this
highlights how histologic/stereologic ap-
proaches, even if laborious and time consuming, are still valu-
able tools for the study of podocyte biology. Additional studies,
especially combining lineage-tracing models and unbiased ste-
reology, are urgently needed to quantify the efﬁciency of glomer-
ular podocyte gain and possible modiﬁable mechanisms.
Figure 5. Large adult glomeruli have more podocytes and lower podocyte density than smaller adult glomeruli and glomeruli from
children. (A) IGV and numbers of podocytes in children (gray circles) and adults (white circles). The solid line represents the line of best ﬁt
in children (linear) and adults (quadratic), and the dotted line shows the beginning of the curve plateau at 43106 mm3. (B) Number of
podocytes in children and adult IGV tertiles (small, medium, and large glomeruli). (C) Podocyte density in children and adult IGV tertiles
(small, medium, and large glomeruli). Children: aggregated data from four infants (6 glomeruli per subject; n=24 glomeruli); adult
IGV tertiles were tertile 1 (small glomeruli), between 0.76 and 1.723106 mm3; tertile 2 (medium glomeruli), between 1.74 and
2.863106 mm3; and tertile 3 (large glomeruli), between 2.94 and 6.913106 mm3. P values directly over the bars represent comparisons
between children (gray bars) and each adult tertile. Bars represent median values with IQR. *P,0.05; **P,0.01; ****P,0.001.
Figure 6. Numbers of NECs, PECs, and podocytes in the context of glomerular volume.
(A) Numbers of podocytes (black circles) and NECs (white circles) in the context of IGV. (B)
NEC-to-podocyte ratio in glomeruli from children and adults by adult IGV tertiles. (C)
Numbers of PECs (black circles) and podocytes (white circles) in the context of IGV. (D)
PEC-to-podocyte ratio in glomeruli from children and adults by adult IGV tertiles. P values
directly over the bars represent comparisons between children (gray bars) and each adult
tertile. Bars represent median values with IQR. ***P,0.001; ****P,0.001.
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To our knowledge, we present for the ﬁrst time the concept of
human podocyte endowment, a term that refers to the number
ofpodocyteswithwhichweareborn.Although the sample sizeof
children in this study is small, we believe that this concept is
important and follows a series of contributions by our group to
understand the role of nephron endowment in the risk, de-
velopment, and progression of renal disease.26,33,69–75 On the
basis of the variation in podocyte number in children and adults,
we postulate that some glomeruli at birth may be better equip-
ped to deal with glomerular stress than others. It is evident that a
more comprehensive analysis of the numbers of podocytes in
newborns and young children is warranted, especially to ﬁnd
associations with low birth weight, prematurity, and adverse
fetomaternal environments. We have commenced studies to an-
swer this critical question.
With the recent interest in the role of podocyte depletion in
glomerular pathology, the question arises as to the optimum
number of podocytes required in a glomerulus to maintain
glomerular health. Wharram et al.5 deﬁned 40% podocyte de-
pletion as the threshold for established glomerular pathology
in a rat model of podocyte injury. Earlier, Lemley et al.31 re-
ported that a similar degree of podocyte loss (approximately
one third) marked the deterioration of glo-
merular structure and function in patients
with IgA nephropathy. However, there is
still no consensus on a reliable cutoff value
for absolute podocyte depletion in the hu-
man kidney. Although this study has
revealed a 3.7-fold variation in podocyte
number per adult glomerulus, at the mo-
ment, we cannot provide a set value for an
optimal podocyte number.
Despite containing more podocytes, hy-
pertrophic adult glomeruli showed a sub-
stantial decrease in podocyte density, which
may already mark an increased risk of
glomerulosclerosis. The aim of glomerular
hypertrophy is to increase ﬁltration surface
area to sustain renal function.76 Previous
studies in animal models and human tissue
have shown that glomerular hypertrophy is
closely associated with endothelial or
mesangial cell hyperplasia.77–79 Therefore,
it is not surprising to ﬁnd a strong association
between glomerular volume and numbers
of NECs, which included endothelial80 and
mesangial81 cells. A recent study by Fukuda
et al.82 showed the critical importance of po-
docyte hypertrophy when compensating
during glomerular hypertrophy. This study
provided evidence that a possible pathway
for pathologic glomerular hypertrophy
was a mismatch between the volume of
podocytes andglomerular volume.82Ourstudy
also indicates that, in hypertrophic human
glomeruli, there is an increase in the NEC-to-podocyte ratio,
providing another piece of evidence to support clear differ-
ences in replication potential of each cell population in the
context of glomerular hypertrophy. Taken together, we pro-
pose that there is evidence of relative podocyte depletion in
hypertrophic glomeruli and that additional studies in path-
ologic tissue will provide critical evidence to deﬁne a threshold
of podocyte density marking the development of glomerulo-
sclerosis.
Interestingly, PECs have gained much attention in recent
years because of their role in the development of glomerulo-
sclerosis.57,59,83,84 Activated PECs can avidly proliferate, mi-
grate, and produce extracellular matrix.85 To our knowledge,
this study provides the ﬁrst estimates of total PEC numbers in
human glomeruli. The numbers of PECs were highly variable
in adult glomeruli (up to a 10.3-fold range) and closely asso-
ciated with glomerular size. The biologic signiﬁcance of higher
numbers of PECs in hypertrophic glomeruli remains unclear,
but multiple hypotheses can be proposed, including (1) pres-
ervation of a physical barrier during glomerular growth, (2)
limited podocyte gain to cope with increases in the ﬁltration
surface area, and (3) early PEC activation.
Figure 7. Possible podocyte sources in the human kidney. (A and A9) Parietal po-
docytes: PECs expressing WT-1 are located close to the vascular pole of a glomerulus
(arrowheads). (B and B9) WT-1+cells were also occasionally observed in the tunica
intima and the tunica media of arterioles in the JGA (asterisks).
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Although subjects included in this studycome fromthe largest
andmost comprehensive kidney autopsy series in the world, this
study has several limitations. We acknowledge the inherent
limitation of a cross-sectional study design. We emphasize that,
although the number of young children included in this study is
small,weusedallavailablesubjects thatmetour inclusioncriteria:
men,CaucasianAmericans, younger than3yearsof age, adequate
birth weight for gestational age, and no intercurrences during
pregnancy.Another limitationwas the inability topresentdata for
endothelial and mesangial cells separately because of the sub-
optimal vWF immunostaining in some of the autopsy samples.
We would advise caution before extrapolating these ﬁndings to
different cohorts (i.e., women and African Americans). Finally,
our selection of glomeruli for cell counting allowed us to com-
pare small and large glomeruli. This sampling strategy assumes
that the relationship between glomerular size and cell numbers is
continuous across the range of glomerular volumes.
In conclusion, this study provides evidence of (1) glomerular
hypertrophy in adult glomeruli and a strong direct association
between glomerular size and numbers of NECs; (2) higher num-
bers of podocytes in large adult glomeruli that may reﬂect both
podocyte endowment at birth and podocyte gain in the postnatal
period; and (3) relative podocyte depletion in large adult glomer-
uli that may increase their risk to develop glomerulosclerosis.
CONCISE METHODS
Subject Selection
SixteenCaucasian-Americanmen and boys were selected for study: four
children (#3 years old) and 12 adults ($18 years old) without renal
disease. The four children presented no complications during pregnancy
and had adequate birth weights for gestational age. Adult subjects pre-
senteddifferentCKDrisk factors (older age, lowNglom, highbody surface
area, hypertension, or cardiovascular-related deaths). Kidneys were ob-
tained fromautopsies performed at theUniversity ofMississippiMedical
Center (Jackson, Mississippi). Ethics approval was obtained in advance
from the Institutional Review Board of the University of Mississippi
Medical Center and the Monash University Human Research Ethics
Committee. On collection, kidneys were perfusion ﬁxed with 10% buff-
ered formalin, bisected, and then immersed in 10% formalin for 10 days.
Representative kidney blocks from the upper pole andmidportion of the
kidney were embedded in parafﬁn as previously described.40
Measurement of Pathologic Parameters
The methodology to assess pathology parameters has been described
in previous publications.73,86 Brieﬂy, representative kidney blocks
from the upper pole and the midportion of each kidney were parafﬁn
embedded. Sections were cut at 4mm and stained with periodic acid–
Schiff-hematoxylin and picrosirius red stains for ﬁbrillar collagen.
Measurement of the percentage of glomerulosclerosis and arterial
intimal thickening (arteriosclerosis) was performed on periodic
acid–Schiff-hematoxylin–stained sections. The percentage of scle-
rotic glomeruli was estimated by counting sclerosed and nonsclerosed
glomerular cross-sections in nonoverlapping 3100 microscopic ﬁelds
moving from the superﬁcial to the inner cortex, with at least 400
glomerular cross-sections being sampled per subject. The severity of
arteriosclerosis was measured as a ratio of the thickness of the intima
to the outer wall diameter at a magniﬁcation of3400 in interlobular
arteries 90–250 mm in diameter using the linear measurement func-
tion of Image-Pro Plus morphometric software (Media Cybernetics
Inc., Bethesda, MD). With the same software, cortical ﬁbrosis was
measured in 3200 images as the proportion of cortex staining red
with the picrosirius stain.
Estimation of Glomerular Volume and Cell Numbers
We estimated IGVs and the absolute numbers of podocytes, NECs, and
PECs per glomerulus using a previously described design–based stereo-
logic approach.12 Thismethod is considered the gold standard for quan-
tiﬁcation of podocyte number and glomerular volume when sufﬁcient
tissue is available.11 In brief, 50 serial parafﬁn sections at 14-mm thick-
ness were obtained for each kidney. Using these sections, 30 glomeruli
(10 glomeruli each from the outer, middle, and inner cortexes) per sub-
jectwere sampled using physical disectors.41,42 Sectionproﬁles of these 30
sampled glomeruli were then imaged using anOlympusDotSlide system,
generally providing between 8 and 16 proﬁles per glomerulus. Glomer-
ular proﬁles were labeled with a ﬂag and a unique identiﬁer. These virtual
images served as maps to ﬁnd all proﬁles of each of these glomeruli
during confocal microscopy. The volumes of all 30 sampled individual
glomeruli per kidney were estimated using the Cavalieri estimator.87
Every second section (in adults) and every section (in children) were
then immunostainedto facilitatecell identiﬁcationandcounting.Sections
were immunostained using an antibody against WT-1 antigen (mono-
clonal mouse anti-human WT-1; M356101, clone 6F-H2 [1:50]; for
podocyte identiﬁcation; DAKO) and an antibody against vWF (1:200),
which in this case,was apolyclonal rabbit anti-humanvWF(A008202; for
endothelial cell identiﬁcation; DAKO). In this study,WT-1 immunostaining
was found exclusively in podocyte cytoplasm. Although immunostaining
for WT-1 is most often reported to be nuclear, it is well known that
WT-1 isoforms are present in the nuclei and cytoplasm of many cell
types, including mousemesonephros, mousemesothelioma, and differen-
tiated embryonic stem cells.88 This localization of WT-1 immunostaining
in podocyte cytoplasm conﬁrms the ﬁndings of the work by Su et al.,30
which used this same antibody and reported immunostaining of human
podocyte cytoplasm, and agrees with the manufacturer’s (DAKO) speciﬁ-
cations regarding this antibody. To further validate thisWT-1 antibody as a
speciﬁc marker of podocyte cytoplasm, we performed double-labeled im-
munostaining for WT-1 and SNP, a well characterized podocyte marker.
BothWT-1 and SNPwere localized in the cytoplasm of the same cells
(Supplemental Figure 1). To ensure that the WT-1 immunostaining
of podocyte cytoplasm in our autopsy samples was not an artifact of
postmortem autolysis, we tested nephrectomy and biopsy samples from
our human tissue bank. In every case, speciﬁc immunostaining of
podocyte cytoplasm was observed (Supplemental Figure 2).
Cells were counted in 96 glomeruli, which were comprised of 6
glomeruli fromeachof 16 subjects. The 6 glomeruli analyzedper subject
were the 3 smallest and the 3 largest (representing the 10th and 90th
percentiles, respectively) from 30 glomeruli per subject used for IGV
estimation. Every immunostained section from each of six subsampled
glomeruli per subject was imaged with a Leica SP5 laser confocal
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microscope (Leica MicroSystems, Manheim, Germany). Optical dis-
sectors were used to sample and therefore, count cells in 8 of 14 mm
available for each glomerular proﬁle (we did not count cells in a 3-mm
guard region at the top and bottomof each section as detailed in ref. 12).
Cells were sampled and counted using optical dissectors on the series of
1-mm confocal optical images, stacked as a virtual slide, and opened
using an ImageJ89 macro. After all newly appearing nuclei had been
identiﬁed, we deﬁned podocytes (tuft cells WT-1+ and vWF2), NECs
(tuft cells WT-12), and PECs (cells located on Bowman’s capsule). Po-
docyte densitywas calculated bydividing absolute podocyte number per
glomerulus by IGV. Cell number ratios were calculated by dividing total
numbers of NECs by total numbers of podocytes (NEC-to-podocyte
ratio) and total numbers of PECs by total numbers of podocytes (PEC-
to-podocyte ratio).
Subjects with the diagnosis of FSGS were excluded from any
stereologic analysis in this autopsy cohort. Importantly, this method
allowed the identiﬁcation of glomeruli with signs of segmental
sclerosis,12 which were excluded from this study.
Statistical Analyses
Data were analyzed using GraphPad Prism, version 5.04 for Windows
(La Jolla, CA) and StataCorp. (Statistical Software: Release 8; StataCorp.,
College Station, TX). Values are expressed as medians6IQRs unless
otherwise stated. Mann–Whitney U test was used to compare variables
with skewed distributions, and Spearman rank coefﬁcient was used as a
measurement of associations. F testswere applied to assess if lines of best
ﬁt were different. Linear regression analysis was performed using IGVas
an independent variable and numbers ofNECs, PECs, and podocytes as
dependent variables. In all instances, a P value,0.05 was considered
statistically signiﬁcant.
ACKNOWLEDGMENTS
Parts of this work were presented in poster format during the American
Society of Nephrology Kidney Week on October 30–November 4, 2012
in San Diego, CA and on November, 11–16, 2014 in Philadelphia, PA.
The authors acknowledge the facilities, scientiﬁc and technical as-
sistance from members of the Monash Micro Imaging Platform and
members of the Monash Histology Platform. V.G.P. received a Monash
Research Graduate School Scholarship and a Faculty of Medicine In-
ternational Postgraduate Scholarship to support his PhD candidature.
This research was funded by the National Health and Medical Research
Council (grant number: 606619).
DISCLOSURES
None.
REFERENCES
1. Saran R, Shahinian V: CKD: A pandemic calling for concerted public
health action. Adv Chronic Kidney Dis 17: 213–214, 2010
2. Wiggins RC: The spectrum of podocytopathies: A unifying view of
glomerular diseases. Kidney Int 71: 1205–1214, 2007
3. Reiser J, Sever S: Podocyte biology and pathogenesis of kidney dis-
ease. Annu Rev Med 64: 357–366, 2013
4. Jefferson JA, Alpers CE, Shankland SJ: Podocyte biology for the bed-
side. Am J Kidney Dis 58: 835–845, 2011
5. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE,
Saunders TL, Dysko RC, Kohno K, Holzman LB, Wiggins RC: Podocyte
depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte
depletion in rats expressing human diphtheria toxin receptor transgene.
J Am Soc Nephrol 16: 2941–2952, 2005
6. Kriz W, Elger M, Nagata M, Kretzler M, Uiker S, Koeppen-Hageman I,
Tenschert S, Lemley KV: The role of podocytes in the development of
glomerular sclerosis. Kidney Int Suppl 45: S64–S72, 1994
7. Mundel P, Shankland SJ: Podocyte biology and response to injury. J
Am Soc Nephrol 13: 3005–3015, 2002
8. Durvasula RV, Shankland SJ: Podocyte injury and targeting therapy: An
update. Curr Opin Nephrol Hypertens 15: 1–7, 2006
9. Shankland SJ: The podocyte’s response to injury: Role in proteinuria
and glomerulosclerosis. Kidney Int 69: 2131–2147, 2006
10. Jefferson JA, Nelson PJ, Najaﬁan B, Shankland SJ: Podocyte disorders:
Core Curriculum 2011. Am J Kidney Dis 58: 666–677, 2011
11. Lemley KV, Bertram JF, Nicholas SB, White K: Estimation of glomerular
podocyte number: A selection of valid methods. J Am Soc Nephrol 24:
1193–1202, 2013
12. Puelles VG, Douglas-Denton RN, Cullen-McEwen L, McNamara BJ,
Salih F, Li J, HughsonMD, HoyWE, Nyengaard JR, Bertram JF: Design-
based stereological methods for estimating numbers of glomerular
podocytes. Ann Anat 196: 48–56, 2014
13. Guo M, Ricardo SD, Deane JA, Shi M, Cullen-McEwen L, Bertram JF: A
stereological study of the renal glomerular vasculature in the db/db
mouse model of diabetic nephropathy. J Anat 207: 813–821, 2005
14. Wei P, Lane PH, Lane JT, Padanilam BJ, Sansom SC: Glomerular
structural and functional changes in a high-fat diet mouse model of
early-stage Type 2 diabetes. Diabetologia 47: 1541–1549, 2004
15. Cusumano AM, Bodkin NL, Hansen BC, Iotti R, Owens J, Klotman PE,
Kopp JB: Glomerular hypertrophy is associated with hyperinsulinemia
and precedes overt diabetes in aging rhesusmonkeys.AmJKidneyDis
40: 1075–1085, 2002
16. Osterby R, Parving HH, Hommel E, Jørgensen HE, Løkkegaard H:
Glomerular structure and function in diabetic nephropathy. Early to
advanced stages. Diabetes 39: 1057–1063, 1990
17. Osterby R, Gundersen HJ, Nyberg G, Aurell M: Advanced diabetic
glomerulopathy. Quantitative structural characterization of non-
occluded glomeruli. Diabetes 36: 612–619, 1987
18. Ijpelaar DH, Schulz A, Koop K, Schlesener M, Bruijn JA, Kerjaschki D,
Kreutz R, deHeer E:Glomerular hypertrophyprecedes albuminuria and
segmental loss of podoplanin in podocytes in Munich-Wistar-Frömter
rats. Am J Physiol Renal Physiol 294: F758–F767, 2008
19. Young RJ, Hoy WE, Kincaid-Smith P, Seymour AE, Bertram JF: Glo-
merular size and glomerulosclerosis in Australian aborigines. Am J
Kidney Dis 36: 481–489, 2000
20. Noël LH: Morphological features of primary focal and segmental glo-
merulosclerosis. Nephrol Dial Transplant 14[Suppl 3]: 53–57, 1999
21. Cahill MM, Ryan GB, Bertram JF: Biphasic glomerular hypertrophy in
rats administered puromycin aminonucleoside. Kidney Int 50: 768–
775, 1996
22. Lee HS, Lim SD: The signiﬁcance of glomerular hypertrophy in focal
segmental glomerulosclerosis. Clin Nephrol 44: 349–355, 1995
23. Suzuki J, Yoshikawa N, Nakamura H: A quantitative analysis of the
glomeruli in focal segmental glomerulosclerosis. Pediatr Nephrol 8:
416–419, 1994
24. Nyberg E, Bohman SO, Berg U: Glomerular volume and renal function
in children with different types of the nephrotic syndrome. Pediatr
Nephrol 8: 285–289, 1994
10 Journal of the American Society of Nephrology J Am Soc Nephrol 26: ccc–ccc, 2015
BASIC RESEARCH www.jasn.org
25. Brenner BM: Nephron adaptation to renal injury or ablation. Am J
Physiol 249: F324–F337, 1985
26. Puelles VG, Hoy WE, Hughson MD, Diouf B, Douglas-Denton RN,
Bertram JF: Glomerular number and size variability and risk for kidney
disease. Curr Opin Nephrol Hypertens 20: 7–15, 2011
27. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD,
Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and pro-
gressive glomerular injury in type II diabetes. J Clin Invest 99: 342–348,
1997
28. Meyer TW, Bennett PH, Nelson RG: Podocyte number predicts long-
term urinary albumin excretion in Pima Indians with Type II diabetes
and microalbuminuria. Diabetologia 42: 1341–1344, 1999
29. Dalla VestraM,Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P: Is
podocyte injury relevant in diabetic nephropathy? Studies in patients
with type 2 diabetes. Diabetes 52: 1031–1035, 2003
30. Su J, Li SJ, Chen ZH, Zeng CH, Zhou H, Li LS, Liu ZH: Evaluation of
podocyte lesion in patients with diabetic nephropathy: Wilms’ tumor-1
protein used as a podocyte marker. Diabetes Res Clin Pract 87: 167–
175, 2010
31. Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A, Myers
BD: Podocytopenia and disease severity in IgAnephropathy.Kidney Int
61: 1475–1485, 2002
32. WangG, Lai FM, KwanBC, Lai KB, ChowKM, Li PK, Szeto CC: Podocyte
loss in human hypertensive nephrosclerosis. Am J Hypertens 22: 300–
306, 2009
33. Zimanyi MA, Hoy WE, Douglas-Denton RN, Hughson MD, Holden LM,
Bertram JF: Nephron number and individual glomerular volumes in
male Caucasian and African American subjects. Nephrol Dial Trans-
plant 24: 2428–2433, 2009
34. Boulet SL, Schieve LA, Boyle CA: Birth weight and health and de-
velopmental outcomes in US children, 1997-2005.Matern Child Health
J 15: 836–844, 2011
35. Stackhouse S, Miller PL, Park SK, Meyer TW: Reversal of glomerular
hyperﬁltration and renal hypertrophy by bloodglucose normalization in
diabetic rats. Diabetes 39: 989–995, 1990
36. Fabris B, Candido R, Armini L, Fischetti F, Calci M, Bardelli M, Fazio M,
Campanacci L, Carretta R: Control of glomerular hyperﬁltration and
renal hypertrophy by an angiotensin converting enzyme inhibitor pre-
vents the progression of renal damage in hypertensive diabetic rats. J
Hypertens 17: 1925–1931, 1999
37. Herbach N, Schairer I, Blutke A, Kautz S, Siebert A, Göke B, Wolf E,
Wanke R: Diabetic kidney lesions of GIPRdn transgenic mice: Podocyte
hypertrophy and thickening of the GBM precede glomerular hyper-
trophy and glomerulosclerosis. Am J Physiol Renal Physiol 296: F819–
F829, 2009
38. Lemley KV: A basis for accelerated progression of diabetic nephropa-
thy in Pima Indians. Kidney Int Suppl 83: S38–S42, 2003
39. Cortes P, Zhao X, Dumler F, Tilley BC, Atherton J: Age-related changes
in glomerular volume and hydroxyproline content in rat and human. J
Am Soc Nephrol 2: 1716–1725, 1992
40. Hughson M, Farris AB 3rd, Douglas-Denton R, Hoy WE, Bertram JF:
Glomerular number and size in autopsy kidneys: The relationship to
birth weight. Kidney Int 63: 2113–2122, 2003
41. Puelles VG, Zimanyi MA, Samuel T, HughsonMD, Douglas-Denton RN,
Bertram JF, Armitage JA: Estimating individual glomerular volume in
the human kidney: Clinical perspectives. Nephrol Dial Transplant 27:
1880–1888, 2012
42. Samuel T, Hoy WE, Douglas-Denton R, Hughson MD, Bertram JF:
Determinants of glomerular volume in different cortical zones of the
human kidney. J Am Soc Nephrol 16: 3102–3109, 2005
43. Hoy WE, Hughson MD, Zimanyi M, Samuel T, Douglas-Denton R,
Holden L, Mott S, Bertram JF: Distribution of volumes of individual
glomeruli in kidneys at autopsy: Associationwith age, nephron number,
birth weight and body mass index. Clin Nephrol 74[Suppl 1]: S105–
S112, 2010
44. Hoy WE, Hughson MD, Diouf B, Zimanyi M, Samuel T, McNamara BJ,
Douglas-Denton RN, Holden L, Mott SA, Bertram JF: Distribution of
volumes of individual glomeruli in kidneys at autopsy: Association with
physical and clinical characteristics and with ethnic group. Am J
Nephrol 33[Suppl 1]: 15–20, 2011
45. Hughson MD, Puelles VG, Hoy WE, Douglas-Denton RN, Mott SA,
Bertram JF: Hypertension, glomerular hypertrophy and nephro-
sclerosis: The effect of race. Nephrol Dial Transplant 29: 1399–1409,
2014
46. Puelles VG, Douglas-Denton RN, Zimanyi MA, Armitage JA, Hughson
MD, Kerr PG, Bertram JF: Glomerular hypertrophy in subjects with low
nephron number: Contributions of sex, body size and race. Nephrol
Dial Transplant 29: 1686–1695, 2014
47. Olivetti G, Anversa P, Melissari M, Loud AV: Morphometry of the renal
corpuscle during postnatal growth and compensatory hypertrophy.
Kidney Int 17: 438–454, 1980
48. Marshall CB, Shankland SJ: Cell cycle regulatory proteins in podocyte
health and disease. Nephron, Exp Nephrol 106: e51–e59, 2007
49. Marshall CB, Shankland SJ: Cell cycle and glomerular disease: A min-
ireview. Nephron, Exp Nephrol 102: e39–e48, 2006
50. Grifﬁn SV, Hiromura K, Pippin J, Petermann AT, Blonski MJ, Krofft R,
Takahashi S, Kulkarni AB, Shankland SJ: Cyclin-dependent kinase 5 is a
regulator of podocyte differentiation, proliferation, and morphology.
Am J Pathol 165: 1175–1185, 2004
51. Hiromura K, Haseley LA, Zhang P, Monkawa T, Durvasula R, Petermann
AT, Alpers CE, Mundel P, Shankland SJ: Podocyte expression of the
CDK-inhibitor p57 during development and disease. Kidney Int 60:
2235–2246, 2001
52. Combs HL, Shankland SJ, Setzer SV, Hudkins KL, Alpers CE: Expression
of the cyclin kinase inhibitor, p27kip1, in developing andmature human
kidney. Kidney Int 53: 892–896, 1998
53. Conaldi PG, Bottelli A, Baj A, Serra C, Fiore L, Federico G, Bussolati B,
Camussi G: Human immunodeﬁciency virus-1 that induces hyper-
proliferation and dysregulation of renal glomerular epithelial cells. Am
J Pathol 161: 53–61, 2002
54. Lasagni L, Lazzeri E, Shankland SJ, Anders HJ, Romagnani P: Podocyte
mitosis - a catastrophe. Curr Mol Med 13: 13–23, 2013
55. Mundel P, Reiser J, Kriz W: Induction of differentiation in cultured rat
and human podocytes. J Am Soc Nephrol 8: 697–705, 1997
56. Pippin JW, Sparks MA, Glenn ST, Buitrago S, Coffman TM, Dufﬁeld JS,
Gross KW, Shankland SJ: Cells of renin lineage are progenitors of po-
docytes and parietal epithelial cells in experimental glomerular dis-
ease. Am J Pathol 183: 542–557, 2013
57. Smeets B, Moeller MJ: Parietal epithelial cells and podocytes in glo-
merular diseases. Semin Nephrol 32: 357–367, 2012
58. Macconi D, Sangalli F, Bonomelli M, Conti S, Condorelli L, Gagliardini
E, Remuzzi G, Remuzzi A: Podocyte repopulation contributes to re-
gression of glomerular injury induced by ACE inhibition. Am J Pathol
174: 797–807, 2009
59. Shankland SJ, Anders HJ, Romagnani P: Glomerular parietal epithelial
cells in kidney physiology, pathology, and repair. Curr Opin Nephrol
Hypertens 22: 302–309, 2013
60. Zhang J, Hansen KM, Pippin JW, Chang AM, Taniguchi Y, Krofft RD,
Pickering SG, Liu ZH, Abrass CK, Shankland SJ: De novo expression of
podocyte proteins in parietal epithelial cells in experimental aging
nephropathy. Am J Physiol Renal Physiol 302: F571–F580, 2012
61. Pichaiwong W, Hudkins KL, Wietecha T, Nguyen TQ, Tachaudomdach
C, Li W, Askari B, Kobayashi T, O’Brien KD, Pippin JW, Shankland SJ,
Alpers CE: Reversibility of structural and functional damage in a model
of advanced diabetic nephropathy. J Am Soc Nephrol 24: 1088–1102,
2013
62. Poulsom R, Forbes SJ, Hodivala-Dilke K, Ryan E, Wyles S,
Navaratnarasah S, Jeffery R, Hunt T, Alison M, Cook T, Pusey C, Wright
NA: Bone marrow contributes to renal parenchymal turnover and re-
generation. J Pathol 195: 229–235, 2001
J Am Soc Nephrol 26: ccc–ccc, 2015 Podocyte Number in Human Glomeruli 11
www.jasn.org BASIC RESEARCH
63. Perry J, Tam S, Zheng K, Sado Y, Dobson H, Jefferson B, Jacobs R,
Thorner PS: Type IV collagen induces podocytic features in bone
marrow stromal stem cells in vitro. J Am Soc Nephrol 17: 66–76, 2006
64. Prodromidi EI, Poulsom R, Jeffery R, Roufosse CA, Pollard PJ, Pusey
CD, Cook HT: Bone marrow-derived cells contribute to podocyte re-
generation and amelioration of renal disease in a mouse model of
Alport syndrome. Stem Cells 24: 2448–2455, 2006
65. Shankland SJ, Smeets B, Pippin JW,Moeller MJ: The emergence of the
glomerular parietal epithelial cell. Nat Rev Nephrol 10: 158–173, 2014
66. WannerN, Hartleben B, HerbachN,GoedelM, Stickel N, Zeiser R,Walz
G, Moeller MJ, Grahammer F, Huber TB: Unraveling the role of
podocyte turnover in glomerular aging and injury. J Am Soc Nephrol
25: 707–716, 2014
67. Berger K, Schulte K, Boor P, Kuppe C, van Kuppevelt TH, Floege J,
Smeets B, Moeller MJ: The regenerative potential of parietal epithelial
cells in adult mice. J Am Soc Nephrol 25: 693–705, 2014
68. Berger K, Moeller MJ: Podocytopenia, parietal epithelial cells and
glomerulosclerosis. Nephrol Dial Transplant 29: 948–950, 2014
69. Walker KA, Bertram JF: Kidney development: Core curriculum 2011.
Am J Kidney Dis 57: 948–958, 2011
70. Bertram JF, Douglas-Denton RN, Diouf B, Hughson MD, Hoy WE:
Human nephron number: Implications for health and disease. Pediatr
Nephrol 26: 1529–1533, 2011
71. Hughson MD, Gobe GC, Hoy WE, Manning RD Jr., Douglas-Denton R,
Bertram JF: Associations of glomerular number and birth weight with
clinicopathological features of African Americans and whites. Am J
Kidney Dis 52: 18–28, 2008
72. Hoy WE, Bertram JF, Denton RD, Zimanyi M, Samuel T, Hughson MD:
Nephron number, glomerular volume, renal disease and hypertension.
Curr Opin Nephrol Hypertens 17: 258–265, 2008
73. Hughson MD, Douglas-Denton R, Bertram JF, Hoy WE: Hypertension,
glomerular number, and birth weight in African Americans and white
subjects in the southeastern United States. Kidney Int 69: 671–678, 2006
74. Hoy WE, Hughson MD, Singh GR, Douglas-Denton R, Bertram JF: Re-
duced nephron number and glomerulomegaly in Australian Aborigi-
nes: A group at high risk for renal disease and hypertension. Kidney Int
70: 104–110, 2006
75. Douglas-Denton RN, McNamara BJ, Hoy WE, Hughson MD, Bertram
JF: Does nephron number matter in the development of kidney dis-
ease? Ethn Dis 16: S2-40-5, 2006
76. Mauer SM, Lane P, Zhu D, Fioretto P, Steffes MW: Renal structure and
function in insulin-dependent diabetes mellitus in man. J Hypertens
Suppl 10: S17–S20, 1992
77. Steffes MW, Schmidt D, McCrery R, Basgen JM; International Diabetic
Nephropathy Study Group: Glomerular cell number in normal subjects
and in type 1 diabetic patients. Kidney Int 59: 2104–2113, 2001
78. White KE, Bilous RW, Marshall SM, El Nahas M, Remuzzi G, Piras G, De
Cosmo S, Viberti G: Podocyte number in normotensive type 1 diabetic
patients with albuminuria. Diabetes 51: 3083–3089, 2002
79. Nadasdy T, Laszik Z, Blick KE, Johnson LD, Silva FG: Proliferative ac-
tivity of intrinsic cell populations in the normal human kidney. J Am Soc
Nephrol 4: 2032–2039, 1994
80. DaneMJ, van denBerg BM, AvramutMC, Faas FG, van der Vlag J, Rops
AL, Ravelli RB, Koster BJ, van Zonneveld AJ, Vink H, Rabelink TJ:
Glomerular endothelial surface layer acts as a barrier against albumin
ﬁltration. Am J Pathol 182: 1532–1540, 2013
81. Abboud HE: Mesangial cell biology. Exp Cell Res 318: 979–985, 2012
82. Fukuda A, Chowdhury MA, Venkatareddy MP, Wang SQ, Nishizono R,
Suzuki T, Wickman LT, Wiggins JE, Muchayi T, Fingar D, Shedden KA,
Inoki K, Wiggins RC: Growth-dependent podocyte failure causes glo-
merulosclerosis. J Am Soc Nephrol 23: 1351–1363, 2012
83. Moeller MJ, Kuppe C: Glomerular disease: The role of parietal epi-
thelial cells in hyperplastic lesions. Nat Rev Nephrol 10: 5–6, 2014
84. Romagnani P: Parietal epithelial cells: Their role in health and disease.
Contrib Nephrol 169: 23–36, 2011
85. Smeets B, Kuppe C, Sicking EM, Fuss A, Jirak P, van Kuppevelt TH,
Endlich K, Wetzels JF, Gröne HJ, Floege J, Moeller MJ: Parietal epi-
thelial cells participate in the formation of sclerotic lesions in focal
segmental glomerulosclerosis. J Am Soc Nephrol 22: 1262–1274,
2011
86. Hoy WE, Douglas-Denton RN, Hughson MD, Cass A, Johnson K,
Bertram JF: A stereological study of glomerular number and volume:
Preliminary ﬁndings in a multiracial study of kidneys at autopsy. Kidney
Int Suppl 83: S31–S37, 2003
87. Gundersen HJ, Jensen EB: The efﬁciency of systematic sampling in
stereology and its prediction. J Microsc 147: 229–263, 1987
88. Niksic M, Slight J, Sanford JR, Caceres JF, Hastie ND: The Wilms’ tu-
mour protein (WT1) shuttles between nucleus and cytoplasm and is
present in functional polysomes. Hum Mol Genet 13: 463–471, 2004
89. Collins TJ: ImageJ for microscopy. Biotechniques 43[Suppl]: 25–30,
2007
This article contains supplemental material online at http://jasn.asnjournals.
org/lookup/suppl/doi:10.1681/ASN.2014070641/-/DCSupplemental.
12 Journal of the American Society of Nephrology J Am Soc Nephrol 26: ccc–ccc, 2015
BASIC RESEARCH www.jasn.org
